Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 478.79 (-2.91 / -0.60%) | 477.10 (-4.60 / -0.95%) | 476.10 (-1.00 / -0.21%) |
| 31-Jul 09:16 | 31-Jul 16:00 | 31-Jul 19:02 |
Sector: Healthcare || Industry: Biotechnology
| Previous Close | 481.70 | Year Low | 362.50 |
| Open | 477.24 | Year High | 533.67 |
| Day Low | 469.87 | Price Avg 50 | 467.45 |
| Day High | 480.67 | Price Avg 200 | 452.59 |
| Volume | 912.21 K | Market Cap | 121.09 B |
News
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| VRTX | -0.95 | 0.22 | -3.95 | 11.63 | 1.53 | 4.43 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/04/2026 | AMC | VRTX | Vertex Pharmaceuticals | Q1 2026 | EPS | 4.31 | 4.47 | 3.71 | 4.06 | 10.10 | |
| 05/04/2026 | AMC | VRTX | Vertex Pharmaceuticals | Q1 2026 | REV | 3.03 B | 2.99 B | -1.48 | 2.77 B | 7.83 | |
| 02/12/2026 | AMC | VRTX | Vertex Pharmaceuticals | Q4 2025 | EPS | 5.07 | 5.03 | -0.79 | 3.98 | 26.40 | |
| 02/12/2026 | AMC | VRTX | Vertex Pharmaceuticals | Q4 2025 | REV | 3.18 B | 3.19 B | 0.45 | 2.91 B | 9.62 | |
| 11/03/2025 | AMC | VRTX | Vertex Pharmaceuticals | Q3 2025 | EPS | 4.56 | 4.80 | 5.26 | 4.38 | 9.60 | |
| 11/03/2025 | AMC | VRTX | Vertex Pharmaceuticals | Q3 2025 | REV | 3.05 B | 3.08 B | 0.74 | 2.77 B | 10.97 | |
| 08/04/2025 | AMC | VRTX | Vertex Pharmaceuticals | Q2 2025 | EPS | 4.29 | 4.52 | 5.36 | -12.83 | ||
| 08/04/2025 | AMC | VRTX | Vertex Pharmaceuticals | Q2 2025 | REV | 2.90 B | 2.97 B | 2.21 | 2.65 B | 12.06 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/12/2026 | 04:01 PM | VRTX | Vertex Pharmaceuticals | FY 2026 | REV | $13.02 B | $12.95 B ~ $13.10 B | 0.00 | 13,025.00 | 0.02 | 44,182 |
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 05/06/2026 | VRTX | Barclays | Overweight | Overweight | Maintain |
| 05/05/2026 | VRTX | Bernstein | Outperform | Outperform | Maintain |
| 05/05/2026 | VRTX | Canaccord Genuity | Hold | Hold | Maintain |
| 05/05/2026 | VRTX | Morgan Stanley | Overweight | Overweight | Maintain |
| 05/05/2026 | VRTX | RBC Capital | Outperform | Outperform | Maintain |
| 04/30/2026 | VRTX | Canaccord Genuity | Hold | Hold | Maintain |
| 04/10/2026 | VRTX | Morgan Stanley | Overweight | Overweight | Maintain |
| 03/18/2026 | VRTX | Maxim Group | Buy | Hold | Upgrade |
| 03/11/2026 | VRTX | Truist Securities | Buy | Buy | Maintain |
| 03/10/2026 | VRTX | Oppenheimer | Outperform | Outperform | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|
Sign-Up to see the full list of CATALYSTS in the Calendars
